enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Amneal Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Amneal_Pharmaceuticals

    In 2018, Amneal Pharmaceuticals LLC merged with Impax Laboratories, Inc. to form Amneal Pharmaceuticals, Inc. Shares of newly public AMRX began trading on the NYSE on May 7, 2018. [9] Concurrent with the Impax merger, Amneal acquired Gemini Laboratories for $117 million, including Unithroid, Gemini's lead product for treating hypothyroidism. [10]

  3. Levothyroxine - Wikipedia

    en.wikipedia.org/wiki/Levothyroxine

    Levothyroxine. Levothyroxine, also known as L-thyroxine, is a synthetic form of the thyroid hormone thyroxine (T 4 ). [ 5][ 8] It is used to treat thyroid hormone deficiency (hypothyroidism), including a severe form known as myxedema coma. [ 5] It may also be used to treat and prevent certain types of thyroid tumors. [ 5]

  4. Mylan - Wikipedia

    en.wikipedia.org/wiki/Mylan

    Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn , Pfizer 's off-patent medicine division, to form Viatris . [ 1 ] Previously, the company was domiciled in the Netherlands , with principal executive offices in Hatfield, Hertfordshire , UK [ 2 ] and a "Global Center" in Canonsburg ...

  5. The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug ...

    www.aol.com/news/daily-biotech-pulse-mylan...

    For premium support please call: 800-290-4726 more ways to reach us

  6. There’s a problem that caused one batch of insulin injection ...

    www.aol.com/news/problem-caused-one-batch...

    If you have questions regarding this recall, email at customer.service@viatris.com or call Viatris at 800-796-9526, Monday through Friday, 8 a.m. to 5 p.m., Eastern time.

  7. Viatris' Mylan Recalls One Batch Of Insulin Glargine Due To ...

    www.aol.com/news/viatris-mylan-recalls-one-batch...

    Bhd. and was distributed by Mylan Specialty L.P. in the U.S. between December 9, 2021, and March 4, 2022. The company said that for Viatris' Mylan Recalls One Batch Of Insulin Glargine Due To ...

  8. The St. Regis Mohawk Tribe and Restasis patent - Wikipedia

    en.wikipedia.org/wiki/The_St._Regis_Mohawk_Tribe...

    Saint Regis Mohawk Tribe v. Mylan Pharms. Inc., 896 F.3d 1322 (Fed. Cir. 2018) is a United States Patent case, decided by the CAFC, deciding whether or not indigenous tribes' sovereign immunity extended to patent lawsuits. In September 2017, the American pharmaceutical company Allergan agreed to transfer six pharmaceutical patents for the ...

  9. US DOJ drops Viatris unit Mylan from industry-wide ... - AOL

    www.aol.com/news/us-doj-drops-viatris-unit...

    July 2, 2024 at 8:17 AM. (Reuters) -Viatris unit Mylan is no longer a subject of the U.S. Department of Justice's antitrust investigation into alleged price fixing in the generic drug industry ...